SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Progress Update

15 Feb 2010 07:00

RNS Number : 1159H
Ashley House PLC
15 February 2010
 



 

Progress Update

Following the interim results announced on 26 January Ashley House is pleased to confirm that two of its delayed projects (East London and Bristol) have now reached financial close releasing accrued revenue into cash. In addition the Company has completed as planned the sales of the minority LIFT investment stakes acquired with Sapphire in November 2009. The total proceeds from these disposals and the release of the accrued revenue has generated £3.34m in cash for Ashley House.

South East Resource Centre (SERC), Hackney East London

This 2,250m² building will accommodate primary and community care teams serving the South East of Hackney. Ithas a design-and-build value of £5.85m to Ashley House. This income will be recognised over the next 12 months. This resource centre is one of four projects in Hackney arising from the polyclinic programme. The schemes are delivered through the East London NHS LIFT Company in which Ashley House is a shareholder and development partner as well as design and build contractor for this scheme. Whilst the SERC project had been ready to go on site for some time the project was finally approved by NHS London (the Strategic Health Authority) as it announced plans for 100 polyclinics across London. Almost one third of these appear in NHS LIFT areas where Ashley House is the development partner.

South Bristol Community Hospital

This 11,000m² Community Hospital is being delivered through the Bristol LIFT Company where Ashley House is a shareholder and development partner. The project enables NHS Bristol to reconfigure service delivery in South Bristol. As with the East London SERC, the project has achieved financial close behind its first anticipated schedule and whilst bringing the Company a relatively small ongoing fee stream its approval releases the accrued income as cash and allows us to develop future opportunities with the PCT with renewed confidence.

The remaining three projects specifically referred to as having experienced delays in the interim results statement are expected to reach financial close in the coming weeks..

Sale of minority Sapphire LIFT investment interests

As reported in our statement of 26 Jan we had agreed to sell the minority NHS LIFT investment interests acquired with Sapphire to the other existing consortium partners. We are pleased to confirm that these sales have now completed.

Chief Executive Jonathan Holmes commented: "This has been a positive couple of weeks for Ashley House. The approval of delayed schemes following detailed review by a cost conscious NHS underlines the importance that moving care into community settings has in saving money whilst improving service to patients. The plan for 100 polyclinics has been re-affirmed by NHS London and working alongside our partners we have successfully closed our first project of a possible 30 arising from this programme alone."

Enquiries:

 

Ashley House plc

Jonathan Holmes, Chief Executive

Bruce Walker, Finance Director

 

Tel: 01628 600340

Numis Securities

(NOMAD and broker to Ashley House)

Oliver Cardigan/ Simon Blank/ David Poutney

 

Tel: 020 7260 1000

Citigate Dewe Rogerson

Sarah Gestetner / Ged Brumby

Tel: 020 7638 9571

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUVBRRAAUAAR
Date   Source Headline
29th Jun 20189:08 amRNSDirectorate change
10th May 20187:00 amRNSHolding(s) in Company
9th May 20182:05 pmRNSSecond Price Monitoring Extn
9th May 20182:00 pmRNSPrice Monitoring Extension
9th May 20187:00 amRNSTrading Update
3rd May 20185:38 pmRNSDirector/PDMR Shareholding
6th Mar 20183:00 pmRNSDirector Dealing
5th Mar 20187:00 amRNSFinancial Close Scarborough Extra Care
1st Mar 20187:00 amRNSAppointment of Finance Director
23rd Feb 201811:54 amRNSHolding(s) in Company
14th Feb 20188:51 amRNSSale of Pharmacy Interest to Repay Debt - Amended
14th Feb 20187:00 amRNSSale of Pharmacy Interest to Repay Debt
2nd Feb 20189:32 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSInterim Results
30th Jan 20184:31 pmRNSDirectors' & PDMRs' Dealings
22nd Dec 20171:07 pmRNSDirector/PDMR Shareholding
15th Dec 20171:56 pmRNSJoint Venture with Morgan Sindall Investments Ltd
24th Nov 20177:00 amRNSUpdate
7th Nov 201711:00 amRNSHolding(s) in Company
31st Oct 20172:28 pmRNSDirectors' & PDMRs' Dealings
26th Oct 20177:00 amRNSUpdate
25th Oct 201712:35 pmRNSResult of AGM
3rd Oct 201710:45 amRNSHolding(s) in Company
3rd Oct 20179:25 amRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreliminary Results For The Year End 30 April 2017
28th Jul 20174:45 pmRNSDirectors' & PDMRs' Dealings
4th Jul 20174:27 pmRNSDebt Facility from Related Party
28th Apr 20172:20 pmRNSDirectors' & PDMRs' dealings
25th Apr 20173:16 pmRNSDebt Facility from Related Party
27th Mar 201711:09 amRNSDirector Dealing
17th Mar 20173:42 pmRNSDirector Dealing
14th Mar 20171:11 pmRNSAcquisition and Trading Update
22nd Feb 201712:03 pmRNSPosting of Interim Report
30th Jan 20171:27 pmRNSDirectors' & PDMRs' dealings
26th Jan 20177:00 amRNSInterim Report 2016
17th Jan 201710:27 amRNSHolding(s) in Company
7th Dec 20167:00 amRNSReplacement Debt Facility from Related Party
28th Oct 20168:41 amRNSDirectors' & PDMRs' dealings
15th Sep 201610:48 amRNSResult of AGM
23rd Aug 20167:00 amRNSReport and Accounts / AGM
28th Jul 20167:00 amRNSDirectors' & PDMRs' Dealings
13th Jul 201611:58 amRNSDirector/PDMR Shareholding
13th Jul 20167:00 amRNSPreliminary results
29th Apr 20167:00 amRNSTotal Voting Rights
28th Apr 201610:22 amRNSDirectors' & PDMRs' dealings
29th Mar 20167:00 amRNSDirectors & PDMRs dealings
1st Mar 201611:09 amRNSDirector Dealing
10th Feb 20167:00 amRNSAdmission Application Announcement
5th Feb 20165:27 pmRNSPosting of Interim Report
26th Jan 20167:00 amRNSInterim Report 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.